
Whereas menstruation impacts half the world’s inhabitants, dependable instruments to objectively measure menstrual movement and monitor cycle patterns have been nearly absent. Present options depend on self-reporting or on merchandise that present no actionable information, leaving thousands and thousands with out the means to grasp their very own our bodies or to have knowledgeable discussions with healthcare professionals.
Emm’s reply is the world’s first good menstrual cup related to an app, which supplies customers with exact, personalised insights into movement quantity, cycle regularity, and different well being alerts.
Backed by a $9 million seed funding spherical led by Lunar Ventures, alongside contributions from the Labcorp Enterprise Fund, Tiny VC, BlueLion World, Alumni Ventures, and angel buyers together with Amar Shah, Vivek Garipalli, and Harpreet Rai, Emm is getting ready to deliver this groundbreaking know-how to the UK market in early 2026.
The world’s first good menstrual cup
The corporate was based in 2020 by Jenny Button, who observed how menstrual well being has been missed within the quickly evolving discipline of wearable well being know-how.
With the conviction that menstruation deserves measurement and understanding akin to cardiovascular or metabolic well being, Button got down to develop an answer that empowers individuals with correct information to affect their wellbeing and healthcare.
Emm’s flagship product is a menstrual cup crafted from medical-grade silicone, embedded with ultra-thin sensors to measure menstrual movement and monitor cycle traits objectively. The gadget has been fine-tuned over 5 years by way of 1000’s of design iterations and in depth person suggestions, making certain consolation, reliability, and precision.
Its related app routinely collects information, establishing a baseline inside three cycles and unlocking insights into cycle length, regularity, and abnormalities that customers can act on.
In contrast to rivals similar to Clue or Flo Health, which rely closely on handbook monitoring or oblique physiological alerts, Emm combines sensor {hardware} and software program to ship clinical-grade information in a user-friendly kind.
What’s subsequent?
Emm plans to launch initially within the UK in early 2026, with enlargement into worldwide markets, together with america, within the following years.
The corporate goals to evolve its platform right into a dual-purpose instrument for customers and researchers alike, enabling new insights and breakthrough therapies for underdiagnosed menstrual and reproductive well being circumstances, similar to endometriosis.




:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)



Recent Comments